KalshiComprobar disponibilidadKYC requerido2% de comisiónDatos de resolución verificadosCalibración aproximadaProbabilidad implícita actualBefore October 2027 90%Líder entre 5 opciones
Calidad del mercado
48 / 100
Baja calidadVolumen 24h
0 €
Liquidez
6,5 mil €
Liquidez mediaCompra / Venta
32.0% / 36.0%
Spread
4.0 pt
Spread moderadoDatos de mercado
Actualizado hace 13 minutos
16 may 26, 2:301 ene 27, 4:59
Tendencias
Solo fondos simulados, sin dinero realNo es asesoramiento financiero
Resultado elegido
Before Jan 1, 202736%
Tendencia de volumen
$132 jul20d de datos27 jul
Mercados Relacionados
Hantavirus pandemic in 2026?
98,4 mil €Sí: 3%
POLYMARKET
POLYMARKET
# of views of MrBeast video day 3?
6,9 mil €26-27M: 78%POLYMARKET
POLYMARKET
New pandemic in 2026?
5,2 mil €Sí: 9%POLYMARKET
POLYMARKET
Measles cases in 2026?
2,4 mil €Above 3000: 94%KALSHI
KALSHI
Pandemic in 2026?
2 mil €Sí: 5%KALSHI
KALSHI
Cyclosporiasis cases reported in the US in 2026?
1,2 mil €Above 20k: 34%KALSHI
KALSHIActivos en estos temas
Reglas
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.